Financial Proceeds - The net proceeds from the company's shares listed on the Stock Exchange and the issuance of over-allotment shares amounted to approximately HKD 428.7 million (equivalent to RMB 336.4 million) as of December 31, 2023[4]. Research and Development - Approximately HKD 123.7 million is allocated for establishing a research and development testing center, with an expected full utilization by mid-2025[5]. Capacity Enhancement - Around HKD 94.9 million is designated for future capacity enhancement of the group, also expected to be fully utilized by mid-2025[5]. Information Technology and Logistics - Approximately HKD 25.7 million is planned for the establishment of an information technology and logistics control center, with full utilization expected by mid-2025[8]. Remaining Proceeds - The remaining unutilized net proceeds amount to approximately RMB 4.5 million, which the company plans to fully utilize by mid-2025[10].
中生联合(03332) - 2024 - 年度业绩